Palatin Technologies Inc. (PTN)

[goodfela58]

Long-term the total sales will hold merit but short-term (the next 3 to 4 months) sales are irrelevant as Vyleesi won’t even go on market until September. In the meantime they will get $60 million dollars and probably a very nice earnings report in September. Some analysts are saying 6 cents a share which would be a 650% growth yoy.

Going back to sales their first royalty payment would be $25 million on $250 million Vyleesi sales. That number is a moderate number and very doable even if sales are just mediocre. Regardless they won’t have to spend any money on marketing so they only stand to gain money which could be up to $300 million total in royalties.

Now let’s throw in the fact that they also have other drugs in clinical trials and two more in phase 1 and a market cap of $215 million. Also, factor in that 9 form 4s were filed today indicating a nice amount of insider buying by 9 individuals.

Sure the stock took a hit but it would be my guess that we could double or triple from here after their financials. Truth be told is that what has transpired over the past week is all really good news and I think investors are going to realize that very soon.